
Publication|Articles|May 1, 2003
The American Journal of Managed Care
- May 2003
- Volume 9
- Issue 5
Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience
Author(s)Darren Kocs, MD, MHSA, A. Mark Fendrick, MD
Advertisement
Articles in this issue
over 22 years ago
Lansoprazole Overutilization: Methods for Step-Down TherapyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
CD19 CAR T-Cell Therapy Shows Promising Activity in Richter Transformation
2
5 AI and Digital Health Advances Transforming Breast Cancer Care and Research
3
2025 Hypertension Guideline Updates Presented at AHA Scientific Sessions
4
Can a Coffee a Day Keep AFib Away?
5















































